ATG7 and colorectal carcinoma: Additionally, treatments with shATG7 and ATG7-IN-1 significantly decreased the GSH/GSSG ratio within CRC cells (Fig. 5G), indicating that ATG7 inhibition changes the redox homeostasis in CRC cells by causing oxidative stress.